
:max_bytes(150000):strip_icc()/Fibrosolve-product-57ab73605f9b58974a323e6f.jpg)
This should encourage the performance of a screening breast sonography in women with PCO. Breast lumpiness is known by many different names, such as fibrocystic disease and fibroid breasts.

Though the word fibrocystic may sound scary, the changes in breast tissue that a woman experiences when she has fibrocystic breast disease are benign. Fibrocystic breast disease is so common in women that, to call it a disease may not be accurate. This study showed a significant association between PCO and benign pathology. See more detailed information on PCOS after the ovarian cysts symptoms list. In group B there was association between PCO and breast pathology in 30 (56.98%) women, while in group C on 6 over 7 (91.66%). In group A (6.83%) women showed breast pathology. Although it is called polycystic ovary/ovarian syndrome, PCOS is not primarily defined by ovarian cysts.8 Rather, PCOS is defined by the presence of at least two of three diagnostic criteria. Women by the US findings were allocated into three groups: 203 over 264 showed NAO (group A) 54 had PAO/PCO (group B) and 7 had PCOS (group C). To better understand what PCOS is, it is important to know how PCOS is defined and categorized. The relationship between pelvic and mammographic scan findings were studied and the chi 2 analysis was used to examine them.

All the subject were examined using an Aloka SSD ZOOO and Esaote AU3 ultrasound equipment with 3.5 MHz and 10 MHz probes for pelvic and mammographic scan respectively. Patients between 18 and 30 years of age, not using oral contraceptives, both with Normal Appearing Ovariest (NAO) or with PCO Polycystic Appearing Ovaries (PAO) enrolled in the study, informed and agreed to undergo ultrasound mammography. Breast changes that fluctuate with the menstrual cycle and have a ropelike texture are considered normal. fibrocystic breast disease and increased prevalence of BBD in these patients 5,6, in. It is known that hyperestrogenism and anovulation are involved in the etiology of the fibrocystic breast disease we evaluated the incidence of this disorder in women with PCO or Polycystic Ovary Sindrome (PCOS) based on ultrasound findings both pelvic and mammographic.įrom January 1995 to December 1997 we performed in our outpatient ultrasound service (I Divisione I Istituto di Clinica Ostetrica e Ginecologica, Università di Roma "La Sapienza") pelvic standard scan on 980 women. Previous studies have reported a significant association between PCOS and benign breast diseases (BBD), e.g. The aim of this study was to assess whether or not there was an association between polycystic ovaries (PCO) and fibrocystic breast disease.
